Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors. - Ahn JS; Hong JY; Park JO; Lee SY; Kim S; Yun HY; Ock CY; Hwang W; Kim SH; Kim HT; Lim HY (Cancer research and treatment, 2025)